ADC Therapeutics SA annual operating expenses
2018
2019
2020
2021
2022
2023
2024
2025
ADC Therapeutics SA Operating Expenses Growth & History (ADCT)
ADC Therapeutics SA's operating expenses was $202.9M for fiscal 2025.
View full ADC Therapeutics SA company overviewADC Therapeutics SA annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $202.9M | $1.4M | +0.68% |
| 2024 | 2024-12-31 | $201.5M | −$34.1M | −14.46% |
| 2023 | 2023-12-31 | $235.5M | −$97.7M | −29.32% |
| 2022 | 2022-12-31 | $333.3M | $37.6M | +12.72% |
| 2021 | 2021-12-31 | $295.6M | $76.4M | +34.83% |
| 2020 | 2020-12-31 | $219.3M | $97.5M | +80.11% |
| 2019 | 2019-12-31 | $121.7M | −$5.3M | −4.20% |
| 2018 | 2018-12-31 | $127.1M | — | — |
ADC Therapeutics SA quarterly operating expenses
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $39.7M | −$8.9M | −18.32% |
| Q1 2026 | 2026-03-31 | $42.5M | −$6.7M | −13.58% |
| Q4 2025 | 2025-12-31 | $39.5M | — | — |
| Q3 2025 | 2025-09-30 | $45.6M | — | — |
| Q2 2025 | 2025-06-30 | $48.6M | — | — |
| Q1 2025 | 2025-03-31 | $49.2M | −$2.5M | −4.86% |
| Q1 2024 | 2024-03-31 | $51.7M | −$18.9M | −26.78% |
| Q4 2023 | 2023-12-31 | $54.2M | −$26.1M | −32.52% |
| Q3 2023 | 2023-09-30 | $51.9M | −$27.5M | −34.67% |
| Q2 2023 | 2023-06-30 | $58.9M | −$27.8M | −32.03% |
| Q1 2023 | 2023-03-31 | $70.6M | −$16.3M | −18.76% |
| Q4 2022 | 2022-12-31 | $80.3M | $462,000 | +0.58% |
| Q3 2022 | 2022-09-30 | $79.4M | $8.5M | +11.98% |
| Q2 2022 | 2022-06-30 | $86.7M | $12.5M | +16.78% |
| Q1 2022 | 2022-03-31 | $86.9M | $16.2M | +22.92% |
| Q4 2021 | 2021-12-31 | $79.8M | $1.8M | +2.29% |
| Q3 2021 | 2021-09-30 | $70.9M | $18.5M | +35.31% |
| Q2 2021 | 2021-06-30 | $74.2M | $29.3M | +65.17% |
| Q1 2021 | 2021-03-31 | $70.7M | $26.8M | +61.02% |
| Q4 2020 | 2020-12-31 | $78.0M | — | — |
| Q3 2020 | 2020-09-30 | $52.4M | — | — |
| Q2 2020 | 2020-06-30 | $44.9M | — | — |
| Q1 2020 | 2020-03-31 | $43.9M | — | — |
ADC Therapeutics SA operating expenses trends
Over the last five fiscal years, ADC Therapeutics SA's operating expenses decreased from $219.3M to $202.9M, a change of −$16.4M. The latest reported quarter, Q2 2026, shows $39.7M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ADC Therapeutics SA source filings ↗